<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165928</url>
  </required_header>
  <id_info>
    <org_study_id>K2018-09-005</org_study_id>
    <nct_id>NCT04165928</nct_id>
  </id_info>
  <brief_title>Multicenter Study of Tetanus Patients in Fujian Province of China</brief_title>
  <official_title>Multicenter Study of Tetanus Patients in Fujian Province of China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujian Provincial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Tetanus is a life-threatening disease in developing countries, and accompanied by
      a high mortality rate. China is the world's largest developing country, and Fujian Province
      is a typical coastal province in China with a relatively developed economy. Therefore, the
      purpose of this study was to investigate the epidemiology, incidence and management of
      tetanus in Fujian Province and to understand the current treatment and prognosis of tetanus
      patients in China.

      Methods: This was a retrospective multicenter observational study of patients who presented
      with a clinical diagnosis of tetanus at 5 general hospitals in Fujian. Data was analyzed
      using computer software system.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Actual">October 31, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcomes of the tetanus patients</measure>
    <time_frame>2008-01-01~2018-10-31</time_frame>
    <description>The survival data of tetanus patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The hospitalization time.</measure>
    <time_frame>2008-01-01~2018-10-31</time_frame>
    <description>The total length of hospitalization and the length of stay in the ICU.</description>
  </secondary_outcome>
  <enrollment type="Actual">95</enrollment>
  <condition>Tetanus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study included all patients of all age groups and both sexes who presented with a
        clinical diagnosis of tetanus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  This study included all patients of all age groups and both sexes who presented with a
             clinical diagnosis of tetanus.

        Exclusion Criteria:

          -  None.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fujian Provincial Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fujian Provincial Hospital</investigator_affiliation>
    <investigator_full_name>Xiuling Shang</investigator_full_name>
    <investigator_title>Deputy Director of the Physician</investigator_title>
  </responsible_party>
  <keyword>neonatal tetanus</keyword>
  <keyword>tetanus immunization program</keyword>
  <keyword>drug-induced</keyword>
  <keyword>tetanus antitoxin</keyword>
  <keyword>critical care medicine</keyword>
  <keyword>artificial airway</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetanus</mesh_term>
    <mesh_term>Tetany</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

